TGFB1 and neoplasm: PFD can be considered the antagonist of TGF-β with multi-target effects including 1-The anti-fibrotic effects in tumor stroma i.e., downregulation of TGF-β, SMAD3, reducing matrix metalloproteinases (MMPs) and mucin 1 (MUC1), and EMT suppression.